Who we are

celebrating 20 years Our investment case

Aspen has a proud heritage dating back more than 160 years and is committed to sustaining life and promoting healthcare through increasing access to our high quality, affordable medicines and products

 

Broader opportunities

Established platform to further enhance therapeutically focused areas

Weighting towards emerging markets

 

Focus on technically complex products in specialist areas

Record of performance with post-patent molecules

World class production concentrated in steriles and other complex manufacture

 

Financial flexibility to take advantage of profitable opportunities

Strong correlation of earnings to cash flow

 

Established foundation of strong corporate governance

Active participant in the United Nations Global Compact (“UN Global Compact”) initiative

A constituent of the FTSE/JSE Responsible Investment Index

 

Grow sustainable stakeholder value

  Providing
employment
to more than
10 000
employees
worldwide
Delivered
NHEPS
compound
annual growth
rate (“CAGR”)
growth of 35% since listing
Supported
more than 220
Socio-Economic
Development
(“SED”) projects
during the year
Enhanced
access
to quality
affordable medicines
to patients
Significant
investment
in regions
in which we
operate